JPRN-UMIN000003265已完成未知
Prevention of myocardial injury with rosuvastatin during coronary intervention study - PRIMITIVE study
ippon Medical School0 个研究点目标入组 232 人开始时间: 2010年2月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 232
研究概览
简要总结
The incidence of periprocedural MI did not significantly differ between the high and low-dose groups (8.7% vs 18.7%, p = 0.052). In patients who were not taking statins at the time of enrollment, high-dose rosuvastatin significantly suppressed periprocedural MI compared with the low dose. The difference was not significant in patients who were already taking statins .
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with severe renal disease (sCR=>3.0, urine protein +++ urine OB +++) or liver disease (AST>100IU/l, ALT>100IU/l, T-bil>3.0mg/dl, PT<60%, albumin<2.8g/dl) 2. ACS patients who need to receive emergency revascularization 3. Patients with no-PCI indication lesion such as LMT 4. in-stent or para-stent restenosis 5. Patients who cannot take statin 6. malignancy
研究者
相似试验
Unknown
4 期
Comparison of High-Dose Rosuvastatin Versus Low Statin Dose Plus Fenofibrate Versus Low Statin Dose Plus Niacin in the Treatment of Mixed HyperlipidemiaDyslipidemiaNCT01010516University of Ioannina120
进行中（未招募）
不适用
Effect of rosuvastatin on cardiovascular events and mortality after pneumoniaCommunity aquired pneumoniaEUCTR2007-004894-25-SEKarolinska University Hospital Huddinge
已完成
4 期
Impact of High-dose Pretreatment of Rosuvastatin in Patients With Acute Coronary Syndrome Following Off-pump Coronary Artery Bypass: Results From the HIROP-ACS (HIgh-dose Pretreatment of Rosuvastatin During Off-Pump Coronary Bypass in Acute Coronary Syndrome) StudyA Total of 234 Patients With Acute Coronary Syndrome Who Will Undergo OPCAB.NCT01971606Yonsei University234
已完成
4 期
Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic PatientsDiabetesNCT00658463Centre Hospitalier Universitaire Dijon8
终止
3 期
Rosuvastatin for Reduction of Myocardial Damage and Systemic Inflammation During Coronary AngioplastyStable Coronary Artery Disease Undergoing PCINCT02205775G. d'Annunzio University280